Key Takeaways:
- The fundraising follows a $260 million Series B in January 2025.
- The funding comes as healthcare systems on both sides of the Atlantic move decisively toward prevention.
- Neko Health builds technology in-house, including hardware, software, and consumer experience.
Neko Health raises fresh capital ahead of its US launch.
WHO: Founded by Spotify’s Daniel Ek and Hjalmar Nilsonne, Neko Health is a health technology company redefining how people understand and act on their health. At the heart of Neko’s offering is the Neko Health Scan, a 60-minute, comprehensive, noninvasive, and radiation-free health assessment that captures millions of health data points. Using proprietary sensors alongside blood analysis, the scan assesses skin health, including moles and marks; biomarkers to identify prediabetes risk; blood abnormalities; and risk factors linked to metabolic syndrome, stroke, and heart attack. Results are delivered on-site within minutes and discussed during an in-person consultation with a medical professional, providing members with personalized and actionable health findings.
WHY: With its first US clinics opening in New York and other cities this year, Neko will use the funding to scale the future of preventive healthcare.
IN THEIR OWN WORDS: Bejul Somaia, Global Partner, Lightspeed Venture Partners, said, “Over the past eighteen months, Neko Health has demonstrated remarkable innovation and growth, attacking one of the largest markets in the world with breakthrough technology, proven consumer demand, and a clear path to global scale. We believe this is one of the most important healthcare companies of our generation, and we’re proud to deepen...
